Astra's Price of Immortality
Astra's purchase of Merck's share of the company's joint venture may represent an emotional overreaction to the Swedish company's earlier strategic timidity. Few mid-sized companies in the 1980s (Glaxo being a notable exception) were aggressive enough to use their drugs as currency for entering the US market and building a significant presence. Merck was able to take advantage of several of them--including Astra. Now with a warchest gleaned from DuPont's and Astra's repurchase of their joint ventures, Merck, facing its biggest challenges in nearly two decades, can fund a larger marketing effort, more research, or afford the kinds of expensive licensing deals it's heretofore resisted.
You may also be interested in...
Coronavirus Notebook: EMA Issues Guidance On Development Of Variant Vaccines, EU Leaders Urge Production Ramp-Up
A batch of AstraZeneca/Oxford University coronavirus vaccines has arrived in Ghana, the first country in the world to receive vaccines via the COVAX Facility.
Scanwell Health, a leader in smartphone-enabled home diagnostics tests, has announced a partnership with Beckton Dickson.
908 Devices, Zimmer Biomet and Ortho Clinical Diagnostics have all appointed new directors, Biolase promotes executive vice president to chief executive officer role, and more.